التفاصيل البيبلوغرافية
العنوان:
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
المؤلفون:
Timothy G. Call , Neil E. Kay , Esteban Braggio , Eli Muchtar , Sameer A. Parikh , Susan M. Schwager , Thomas E. Witzig , Jose F. Leis , Kari G. Rabe , Daniel L. Van Dyke , Amie Fonder , Saad S. Kenderian , Wei Ding , Paul J. Hampel , Yucai Wang , Amber B. Koehler , Susan L. Slager
المصدر:
American journal of hematologyREFERENCES . 95(3)
سنة النشر:
2019
مصطلحات موضوعية:
Oncology , Male , medicine.medical_specialty , Disease free survival , Combination therapy , Chronic lymphocytic leukemia , Disease-Free Survival , chemistry.chemical_compound , Bridged Bicyclo Compounds , Piperidines , Internal medicine , medicine , Humans , Survival rate , Aged , Aged, 80 and over , Sulfonamides , Venetoclax , business.industry , Adenine , Hematology , Middle Aged , medicine.disease , Bridged Bicyclo Compounds, Heterocyclic , Leukemia, Lymphocytic, Chronic, B-Cell , Survival Rate , Leukemia , Pyrimidines , chemistry , Ibrutinib , Pyrazoles , Female , business
تدمد:
1096-8652
الوصول الحر:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e311febaff680b596fa31d7a21ff2964Test https://pubmed.ncbi.nlm.nih.gov/31788844Test
حقوق:
OPEN
رقم الانضمام:
edsair.doi.dedup.....e311febaff680b596fa31d7a21ff2964
قاعدة البيانات:
OpenAIRE
